EUVIMEDEUVIMED entdecken
Leitlinie

Second Generation of AHOPCA (Asociación de Hemato‐Oncología Pediátrica de Centro América) Treatment Guidelines for Wilms Tumor: A Report of Outcomes

Thelma Velasquez-Herrera iD, Patricia Valverde, Soad Fuentes, Armando Peña, Roberta Ortiz, Patricia Calderon, Margarita Montero, Giovanna Gattuso iD, Jessica Blanco, Magda Arreola, Israel Fernandez-Pineda, Monika Metzger und 3 weitere

Pediatric Blood & Cancer · 2026

DOI: 10.1002/pbc.32148 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Thelma Velasquez-Herrera und 14 weiteren Autor:innen. Beteiligte Einrichtung: Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala. Hauptthemen laut MEDLINE: Wilms Tumor, Kidney Neoplasms, Nephrectomy, Practice Guidelines as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The AHOPCA (Asociación de Hemato‐Oncología Pediátrica de Centro América) Wilms tumor (WT) treatment guidelines, adapted from NWTS‐4 and ‐5 and recommending upfront nephrectomy (UN), were modified to include 4–6 weeks of preoperative chemotherapy (POC) in frail patients with advanced disease. We aim to describe the outcomes of this implemented approach. Procedure A retrospective analysis of prospectively collected data from newly diagnosed patients with unilateral WT between 2012 and 2018.

Results

Of 353 eligible patients, 247 (70%) received POC. The POC group had higher initial tumor volume (median 590 mL vs. 308 mL, p < 0.0001) and more Stage IV disease (30% vs. 3%, p < 0.0001) compared to the UN group. During POC, there were 4 deaths, 14 abandonments, and 11 progressive diseases. After response assessment, 62% showed partial tumor response with a median tumor volume reduction to 257 mL. A total of 218 (88.2%) patients underwent nephrectomy. Tumor rupture/spillage occurred in 17.9% of the UN and 18.8% of the POC group; local Stage III was found in 55% of the UN and 68.3% of the POC group. Anaplasia (focal and diffuse) was present in 13.6% (17% UN and 11.9% POC). The 5‐year abandonment‐sensitive event‐free survival (asEFS) and abandonment‐sensitive overall survival (asOS) rates were 69% ± 2.5% and 75% ± 2.4%, respectively. The asEFS rates were 75% ± 4.3% for UN and 66% ± 3.0% for POC ( p = 0.07).

Conclusions

Many AHOPCA patients presented with unresectable advanced disease, requiring the use of POC. POC effectively reduced tumor volume and facilitated safe surgery in fragile patients. Adopting the standard SIOP WT neoadjuvant approach could enhance staging and risk stratification in AHOPCA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wilms TumorKidney NeoplasmsNephrectomyPractice Guidelines as TopicAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleRetrospective StudiesMaleChild, PreschoolChildInfantPrognosisSurvival RateFollow-Up StudiesAdolescent

Stichwörter der Autor:innen

NWTS 4 and 5SIOP‐WT guidelinesWilms tumorlow‐middle income countriestreatment abandonment

Autor:innen und Institutionen

  • Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala.
  • Hospital Benjamín Bloom, San Salvador, El Salvador.
  • Hospital Escuela Universitario, Tegucigalpa, Honduras.
  • Hospital Manuel de Jesus Rivera, Managua, Nicaragua.
  • Hospital De Niños Robert Reid Cabral, Santo Domingo, Dominican Republic.
  • Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale Dei Tumori di Milano, Milan, Italy.

ORCID-Profile: Thelma Velasquez-Herrera, Giovanna Gattuso, Sandra Luna-Fineman, Filippo Spreafico

Förderung

  • World Health Organization

Zitieren

APA

Velasquez-Herrera, T., Valverde, P., Fuentes, S., Peña, A., Ortiz, R., Calderon, P., Montero, M., Gattuso, G., Blanco, J., Arreola, M., Fernandez-Pineda, I., Metzger, M., Luna-Fineman, S., Wilimas, J., & Spreafico, F. (2026). Second Generation of AHOPCA (Asociación de Hemato‐Oncología Pediátrica de Centro América) Treatment Guidelines for Wilms Tumor: A Report of Outcomes. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32148

Vancouver

Velasquez-Herrera T, Valverde P, Fuentes S, Peña A, Ortiz R, Calderon P, et al. Second Generation of AHOPCA (Asociación de Hemato‐Oncología Pediátrica de Centro América) Treatment Guidelines for Wilms Tumor: A Report of Outcomes. Pediatric Blood & Cancer. 2026. doi:10.1002/pbc.32148

BibTeX
@article{VelasquezHerrera2026,
  author = {Velasquez-Herrera, Thelma and Valverde, Patricia and Fuentes, Soad and Peña, Armando and Ortiz, Roberta and Calderon, Patricia and Montero, Margarita and Gattuso, Giovanna and Blanco, Jessica and Arreola, Magda and Fernandez-Pineda, Israel and Metzger, Monika and Luna-Fineman, Sandra and Wilimas, Judith and Spreafico, Filippo},
  title = {Second Generation of AHOPCA (Asociación de Hemato‐Oncología Pediátrica de Centro América) Treatment Guidelines for Wilms Tumor: A Report of Outcomes},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/pbc.32148}
}
Kostenlos starten →